Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 14/20 | 0.36 |
| ▸ | PTPRF | P10586 | 1/20 | 0.34 |
| ▸ | PTPRA | P18433 | 1/20 | 0.34 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.34 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.34 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.33 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.33 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP13 | P45452 | 1/20 | 0.32 |
| ▸ | MMP14 | P50281 | 1/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4260729 | 0.94 | PTPN1 (0.35) | PTPN1PTPRFPTPRAPTPN7DUSP3 | |
| SCHEMBL4267881 | 0.85 | PTPN1 (0.34) | PTPN1PTPRFPTPRAPTPN7DUSP3 | |
| SCHEMBL4265268 | 0.84 | MMP2 (0.39) | PTPN1PTPRFPTPRAPTPN7DUSP3 | |
| SCHEMBL5743849 | 0.83 | TAS2R14 (0.35) | PTPN1DUSP3SCD5MTNR1AMTNR1B | |
| SCHEMBL4275242 | 0.78 | MMP2 (0.40) | PTPN1PTPRFPTPRAPTPN7DUSP3 | |
| SCHEMBL4275279 | 0.78 | PTPN1 (0.36) | PTPN1PTPRFPTPRAPTPN7DUSP3 | |
| SCHEMBL4800199 | 0.77 | PTPN1 (0.38) | PTPN1PTPRFPTPRAPTPN7DUSP3 | |
| SCHEMBL4261640 | 0.75 | PTPN1 (0.38) | PTPN1PTPRFPTPRAPTPN7DUSP3 | |
| SCHEMBL4271364 | 0.73 | ADAMTS5 (0.52) | PTPN1PTPRFPTPRAPTPN7DUSP3 | |
| SCHEMBL4271368 | 0.73 | ADAMTS5 (0.52) | PTPN1PTPRFPTPRAPTPN7DUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090082392-A1 | Substituted Carboxylic Acids | THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC | 2009-03-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090082392-A1 | Substituted Carboxylic Acids | PTPRJ, PTPRS, PTPRG | PTPN1 16/4885PTPRF 6/4885PTPRA 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.